QIN 0.00% 29.5¢ quintis ltd

What I have noticed with VP's reporting is that it emphasises...

  1. 1,460 Posts.
    What I have noticed with VP's reporting is that it emphasises the negative and accepts negative opinions with little criticism. The Glaucus attack is a case in point - time has shown that it had many flaws yet this aspect has never had much attention. Sure there were issues with the Nestle contract and China but the perpetrator has gone and is subject to legal action. Meanwhile the long term fundamentals remain sound i.e. established market demand, significant lead over any competitor in tree maturity, developing medical market progressing through FDA approval etc. This I consider is shown in the acceptance by major holders of a forbearance arrangement, these people are very hard headed so if they are prepared to wait .....

    As for shorters Gerry Harvey summed them up.

    As a shareholder I also am prepared to wait, I realise that the chances of a dividend this year or next are slim but after that I am confident that the coy will prosper.

    All IMO and DYOR
 
watchlist Created with Sketch. Add QIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.